Skip to main content
Equibles

SPHERA FUNDS MANAGEMENT LTD.

Position in PMN — ProMIS Neurosciences Inc.

CIK 1496201 TEL AVIV, L3
Back to PMN Full portfolio

Position in PMN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,284,777
+$149,772 QoQ
Shares Held
325,591
0.0% QoQ
Ownership
3.63%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#8
of 27 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PMN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $446,002,188 across 71 Biotechnology names. PMN ranks #38 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MLYS
Mineralys Therapeutics, Inc.
 1,469,971 $39,659,817
2 SNDX
Syndax Pharmaceuticals Inc
 1,014,606 $22,179,287
3 RARE
Ultragenyx Pharmaceutical Inc.
 588,494 $19,649,814
4 BMRN
Biomarin Pharmaceutical Inc
 328,550 $18,799,631
5 CYTK
Cytokinetics Inc
 219,987 $18,740,692
6 BBIO
BridgeBio Pharma, Inc.
 245,346 $18,273,370
7 COGT
Cogent Biosciences, Inc.
 459,340 $17,776,458
8 INSM
INSMED Inc
 118,800 $12,666,456

All Filings in PMN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,284,777 325,591
2026-03-31 $4,135,005 325,591
2025-12-31 $80,641 11,807
2025-09-30 $126,930 295,187
2025-06-30 $911,662 1,899,297
2025-03-31 $1,350,507 1,929,297
2024-12-31 $1,832,832 1,929,297
2024-09-30 $2,411,621 1,929,297
2024-06-30 $2,721,319 1,814,213
2024-03-31 $3,503,029 1,834,047
2023-12-31 $2,109,148 1,834,042
2023-09-30 $3,631,403 1,834,042